Opinion
Video
Author(s):
Enhancing minority enrollment in clinical trials and utilizing real-world data improves drug safety and efficacy for mHSPC treatments.
Future Research Directions
Key Themes:
Key Points for Physicians:
Notable Insights: Real-world evidence provides an important complement to clinical trial data, particularly for understanding outcomes in traditionally underrepresented populations.
Clinical Significance: Ongoing commitment to inclusive research and evidence generation will improve the quality and equity of prostate cancer care, particularly for populations historically underrepresented in clinical trials.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.